Caida Lai
Founder
Now Founder, METiS TechBio
Latest on AI4S.fyiFunding · May 13 · founderMETiS TechBio · IPO · about HK$2.113B grossPhotos come from each person's X account, their own site, lab or team page, a conference page that lists them as a speaker in the same role, or Wikimedia Commons under the licence credited, so some may be out of date. Anyone can ask for theirs to be replaced or removed. Contact →
Affiliations
Current
- Founder · METiS TechBio
Also named in the companies' announcements: MIT
Current roles come from these dated records, not from the bio below. Each links the page it was read from.
About
Caida Lai (Tsai-Ta Lai) is a co-founder of METiS TechBio, its CEO since 2020 and chairman of the board. He was CTO of the water-treatment startup AquaFresco and then an associate at McKinsey. He holds a bachelor's in chemical engineering from National Taiwan University and a PhD in chemical engineering from MIT, done at the Novartis-MIT manufacturing research centre.
Read on 2026-09-29; for current roles see Affiliations above. Read at: metistechbio.com ↗ · metistechbio.com ↗
Founded
METiS TechBioDrug discovery · 2020 · 7 rounds on record · disclosed CNY 400M + $250M · IPO about HK$2.113B grossBackground: MIT chemical engineering PhD (Novartis-MIT Center); McKinsey (as the company's own announcements put it)
Co-founders: Hongming Chen, Wenshou Wang
Backed byBeijing Pharma & Health Industry Investment FundDaxing District Industry Investment FundCICC Capital fundPICC CapitalChina Life EquitySequoia China
Nothing else on the record names them yet.
Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →